Induction chemotherapy with MVP (mitomycin-C + vindesine + cisplatin) for stage III (T1-3, N2, M0)...

1

Transcript of Induction chemotherapy with MVP (mitomycin-C + vindesine + cisplatin) for stage III (T1-3, N2, M0)...

Page 1: Induction chemotherapy with MVP (mitomycin-C + vindesine + cisplatin) for stage III (T1-3, N2, M0) unresectable non-small cell lung cancer: The Toronto experience

Pharmaceuticals and Medical Devices Agency - pmda.go.jp · Indications 1. Treatment of unresectable malignant melanoma . 2. Treatment of unresectable, advanced or recurrent non- small

Pharmaceuticals and Medical Devices Agency - pmda.go.jp · Indications 1. Treatment of unresectable malignant melanoma . 2. Treatment of unresectable, advanced or recurrent non- small

Pharmacokinetics of Intravesical Mitomycin C in Superficial ......(CANCER RESEARCH 51. 5144-5152, October I, 1991] Pharmacokinetics of Intravesical Mitomycin C in Superficial Bladder

Pharmacokinetics of Intravesical Mitomycin C in Superficial ......(CANCER RESEARCH 51. 5144-5152, October I, 1991] Pharmacokinetics of Intravesical Mitomycin C in Superficial Bladder

Effect of Mitomycin C on Myopic versus Astigmatic ...downloads.hindawi.com/journals/joph/2017/2841408.pdf · Effect of Mitomycin C on Myopic versus Astigmatic Photorefractive Keratectomy

Effect of Mitomycin C on Myopic versus Astigmatic ...downloads.hindawi.com/journals/joph/2017/2841408.pdf · Effect of Mitomycin C on Myopic versus Astigmatic Photorefractive Keratectomy

Checkpoint Inhibition in the Treatment of Unresectable ...

Checkpoint Inhibition in the Treatment of Unresectable ...

BY MITOMYCIN C - 京都大学repository.kulib.kyoto-u.ac.jp/.../1/D_Ueda_Kazumitsu.pdf · 2018-08-02 · INTRODUCTION Mitomycin C is an anticarclnogenic antibiotic that has demonstrated

BY MITOMYCIN C - 京都大学repository.kulib.kyoto-u.ac.jp/.../1/D_Ueda_Kazumitsu.pdf · 2018-08-02 · INTRODUCTION Mitomycin C is an anticarclnogenic antibiotic that has demonstrated

Effectiveness of Scraping and Mitomycin C to Treat … · Effectiveness of Scraping and Mitomycin C to Treat Haze ... PRK, Scraping. INTRODUCTION Excimer laser photorefractive ...

Effectiveness of Scraping and Mitomycin C to Treat … · Effectiveness of Scraping and Mitomycin C to Treat Haze ... PRK, Scraping. INTRODUCTION Excimer laser photorefractive ...

Locally Advanced, Unresectable Pancreatic Cancer: American ... · what initial assessment is recommended before initiating therapy for locally advanced, unresectable pancreatic cancer?

Locally Advanced, Unresectable Pancreatic Cancer: American ... · what initial assessment is recommended before initiating therapy for locally advanced, unresectable pancreatic cancer?

Y-90 SIR-Spheres Treatment of Unresectable Primary … · Y-90 SIR-Spheres Treatment of Unresectable Primary or Metastatic Liver Tumors J. Machac1, S. Heiba1, M. Jiang1, Z. Zhang1,

Y-90 SIR-Spheres Treatment of Unresectable Primary … · Y-90 SIR-Spheres Treatment of Unresectable Primary or Metastatic Liver Tumors J. Machac1, S. Heiba1, M. Jiang1, Z. Zhang1,

Reduction of mitomycin C resistance in human bladder cancer T24 … · 2018-11-13 · Keywords: Mitomycin C, ras oncogene, T24 cells, bladder cancer, siRNA INTRODUCTION Bladder cancer

Reduction of mitomycin C resistance in human bladder cancer T24 … · 2018-11-13 · Keywords: Mitomycin C, ras oncogene, T24 cells, bladder cancer, siRNA INTRODUCTION Bladder cancer

PHACOTRABECULAECTOMY WITH MITOMYCIN C - FORNIX VS

PHACOTRABECULAECTOMY WITH MITOMYCIN C - FORNIX VS

< versus 5FU_firstrevision_v7_clean.pdf · Mitomycin-C & 5-FU vs. Mitomycin-C & Capecitabine in the Treatment of Anal Cancer with IMRT: a Prospective National Cohort Evaluation 2

< versus 5FU_firstrevision_v7_clean.pdf · Mitomycin-C & 5-FU vs. Mitomycin-C & Capecitabine in the Treatment of Anal Cancer with IMRT: a Prospective National Cohort Evaluation 2

XEN Glaucoma Implant with Mitomycin C 1-Year Follow-Up ...downloads.hindawi.com/journals/joph/2017/5457246.pdf · Clinical Study XEN Glaucoma Implant with Mitomycin C 1-Year Follow-Up:

XEN Glaucoma Implant with Mitomycin C 1-Year Follow-Up ...downloads.hindawi.com/journals/joph/2017/5457246.pdf · Clinical Study XEN Glaucoma Implant with Mitomycin C 1-Year Follow-Up:

Gastrojejunostomy in patients with unresectable pancreatic head …€¦ · Gastrojejunostomy in patients with unresectable pancreatic head cancer - the use of Roux loop significantly

Gastrojejunostomy in patients with unresectable pancreatic head …€¦ · Gastrojejunostomy in patients with unresectable pancreatic head cancer - the use of Roux loop significantly

Experimental and Clinical Activity of Mitomycin C and c/s ......order of activity) were mitomycin C, dacarbazine, 1,3-bis(2-chloroethyl)-1-nitrosourea, bleomycin, and cyclophosphamide.

Experimental and Clinical Activity of Mitomycin C and c/s ......order of activity) were mitomycin C, dacarbazine, 1,3-bis(2-chloroethyl)-1-nitrosourea, bleomycin, and cyclophosphamide.

Conjunctival Limbal Autograft With Fibrin Glue With Mitomycin-C in Managing Recurrent Pterygium

Conjunctival Limbal Autograft With Fibrin Glue With Mitomycin-C in Managing Recurrent Pterygium

Unresectable Pancreas Tumor with Celiac Trunk Encasement ...dlweb01.tzuchi.com.tw/DL/acdactive/content/discuss/... · Unresectable Pancreas Tumor with Celiac Trunk Encasement: the

Unresectable Pancreas Tumor with Celiac Trunk Encasement ...dlweb01.tzuchi.com.tw/DL/acdactive/content/discuss/... · Unresectable Pancreas Tumor with Celiac Trunk Encasement: the

Y-90 SIR-Spheres Treatment of Unresectable Primary or Metastatic

Y-90 SIR-Spheres Treatment of Unresectable Primary or Metastatic

Action du Sulfate de Vindesine sur l'Ultrastructure ...

Action du Sulfate de Vindesine sur l'Ultrastructure ...

Mitomycin C instillation following ureterorenoscopic …applications.emro.who.int/imemrf/Urol_Ann/Urol_Ann_2013_5_3_184... · Mitomycin C instillation following ureterorenoscopic

Mitomycin C instillation following ureterorenoscopic …applications.emro.who.int/imemrf/Urol_Ann/Urol_Ann_2013_5_3_184... · Mitomycin C instillation following ureterorenoscopic

Report on the Deliberation Results - pmda.go.jp · Indications . 1. Unresectable malignant melanoma 2. Unresectable, advanced or recurrent PD-L1 positive non-small cell lung cancer

Report on the Deliberation Results - pmda.go.jp · Indications . 1. Unresectable malignant melanoma 2. Unresectable, advanced or recurrent PD-L1 positive non-small cell lung cancer